Close Menu

NEW YORK – Enzo Biochem reported after the close of the markets on Tuesday that its fiscal first quarter 2020 revenues fell 5 percent year over year, largely due to a decline in clinical services revenues.

For the three months ended Oct. 31, 2019, the company reported total revenues of $20.2 million, down from $21.3 million in the year-ago period.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.